IL10 and psoriasis vulgaris: Studies found that the increased Th2 and Th17 immune response may play a role in EP pathogenesis, endorsed by the higher serum level of interleukin (IL)-13, IL-4, IL-6 and IL-10 in EP patients than patients with plaque psoriasis (32–34).